Ultragenyx Pharmaceutical Inc (RARE) - Financial and Strategic SWOT Analysis Review

  • ID: 4284989
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • Ultragenyx Pharmaceutical
1 of 5


  • B. Braun Medical Inc
  • Escala Therapeutics Inc
  • MORE

Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops life-enhancing therapeutics for rare and ultra-rare genetic diseases. The company’s products comprise KRN23, rhPPCA, rhGUS, UX007 and Aceneuramic acid. Its Aceneuramic acid is developed for multiple rare genetic disorders. Ultragenyx develops recombinant fully human monoclonal IgG1 antibody, KRN23 to treat bone disease X-Linked Hypophosphatemia and tumor-induced osteomalacia. The company also develops investigational enzyme replacement therapies, recombinant human beta-glucuronidase for the development for Mucopolysaccharidosis 7 and rhPPCA for treatment of galactosialidosis. It partners with academic institutes and companies. Ultragenyx is headquartered in Novato, California, the US.

Ultragenyx Pharmaceutical Inc Key Recent Developments

Feb 20, 2018: Ultragenyx Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Update
Jan 29, 2018: Ultragenyx Names Camille L. Bedrosian as Chief Medical Officer and Executive Vice President
Nov 30, 2017: Ultragenyx to Highlight Pipeline at Analyst and Investor Day on December 4
Nov 02, 2017: Ultragenyx Reports Third Quarter 2017 Financial Results and Corporate Update
Jul 27, 2017: Ultragenyx Reports Second Quarter 2017 Financial Results and Corporate Update

This comprehensive SWOT profile of Ultragenyx Pharmaceutical Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ultragenyx Pharmaceutical Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 5


  • B. Braun Medical Inc
  • Escala Therapeutics Inc
  • MORE
Section 1 - About the Company
  • Ultragenyx Pharmaceutical Inc - Key Information
  • Ultragenyx Pharmaceutical Inc - Overview
  • Ultragenyx Pharmaceutical Inc - Key Employees
  • Ultragenyx Pharmaceutical Inc - Key Employee Biographies
  • Ultragenyx Pharmaceutical Inc - Key Operational Heads
  • Ultragenyx Pharmaceutical Inc - Major Products and Services
  • Ultragenyx Pharmaceutical Inc - History
  • Ultragenyx Pharmaceutical Inc - Company Statement
  • Ultragenyx Pharmaceutical Inc - Locations And Subsidiaries
  • Ultragenyx Pharmaceutical Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Ultragenyx Pharmaceutical Inc - Business Description
  • Ultragenyx Pharmaceutical Inc - Corporate Strategy
  • Ultragenyx Pharmaceutical Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Ultragenyx Pharmaceutical Inc - Strengths
  • Ultragenyx Pharmaceutical Inc - Weaknesses
  • Ultragenyx Pharmaceutical Inc - Opportunities
  • Ultragenyx Pharmaceutical Inc - Threats
  • Ultragenyx Pharmaceutical Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Ultragenyx Pharmaceutical Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Ultragenyx Pharmaceutical Inc, Key Information
  • Ultragenyx Pharmaceutical Inc, Key Ratios
  • Ultragenyx Pharmaceutical Inc, Share Data
  • Ultragenyx Pharmaceutical Inc, Major Products and Services
  • Ultragenyx Pharmaceutical Inc, History
  • Ultragenyx Pharmaceutical Inc, Key Employees
  • Ultragenyx Pharmaceutical Inc, Key Employee Biographies
  • Ultragenyx Pharmaceutical Inc, Key Operational Heads
  • Ultragenyx Pharmaceutical Inc, Other Locations
  • Ultragenyx Pharmaceutical Inc, Subsidiaries
  • Ultragenyx Pharmaceutical Inc, Key Manufacturing facilities
  • Ultragenyx Pharmaceutical Inc, Key Competitors
  • Ultragenyx Pharmaceutical Inc, SWOT Analysis
  • Ultragenyx Pharmaceutical Inc, Ratios based on current share price
  • Ultragenyx Pharmaceutical Inc, Annual Ratios
  • Ultragenyx Pharmaceutical Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Ultragenyx Pharmaceutical Inc, Performance Chart
  • Ultragenyx Pharmaceutical Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Escala Therapeutics Inc
  • BioMarin Pharmaceutical Inc
  • B. Braun Medical Inc
  • Alexion Pharmaceuticals Inc
  • Aegerion Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown